Search Videos and More
Clinician’s Guide to Cardio-Oncology: Best Practice and Future Directions
Hosted by the Washington University and Barnes-Jewish Heart & Vascular Center, “Clinician’s Guide to Cardio-Oncology: Best Practice and Future Directions” was presented during the AHA Scientific Sessions on November 10, 2018 in Chicago, Illinois.
What are the Best Approaches to Monitor and Manage Vascular Toxicity in Cardio-Oncology?
Mayo Clinic cardiologist, Joerg Herrmann, MD, provides a review of the three main types of presentation of vascular toxicity seen with chemotherapy: acute vasospasm, acute thrombosis, and accelerated atherosclerosis.
Vascular Surgery and Non-Healing Peripheral Wounds
Vipul Khetarpaul, MD, presents several cases on PAD and Non-Healing Peripheral Wounds.
When to Put on the Vest and When to Take it Off? Appropriate Use of Wearable Defibrillators – 2016 AHA Symposium, Part 1
Dr. Marye Gleva discusses when a patient should wear a cardioverter-defibrillator, the risk factors associated with not wearing one and how a WCD works.
What Clinicians Need to Know About Genetic Testing for Patients and Families with HCM - 2015 AHA Symposium, Part 5
Should you offer genetic testing to your patient with HCM? When you approach genetic testing in patients and families with HCM, it is definitely a shared decision.
2019 Shock Symposium
The Symposium on Contemporary Management of Cardiogenic Shock and Respiratory Failure focused on recent technological advances in the field of cardiogenic shock.
Leveraging Big Data and the EHR to Better Inform the Practice of Cardio-Oncology
Washington University cardiologist at Barnes-Jewish Hospital, Joshua Mitchell, MD, discusses the continually expanding field of available cancer therapies.
Update on Evaluation and Nonsurgical Treatment Strategies for the Symptomatic Patient with HCM - 2015 AHA Symposium, Part 1
HCM, an unexplained hypertrophy not due to some other secondary cause, is a highly variable disease that presents uniquely in each patient.
Coronary Microvascular Function and Diastolic Heart Failure in Women – Cardiology Grand Rounds
Coronary Microvascular Function and Diastolic Heart Failure are two epidemics that can explain the disparities in cardiovascular outcomes in women.
Too Soon? Too Late? When to Refer for Catheter Ablation? – 2016 AHA Symposium, Part 5
Dr. Daniel Cooper discusses the importance of choosing the right patient at the right time for catheter ablation, minimizing ICD shocks and erring on the side of early referral to maximize the benefits for the patient.
Calcific Aortic Stenosis: Key Concepts and the Road Ahead – Cardiology Grand Rounds
Dr. Philippe Pibarot discusses calcific aortic stenosis, looking at key concepts and towards the future.
Do the Genes Fit? When to Order Genetic Testing? – 2016 AHA Symposium, Part 4
Dr. Nathan Stitziel discusses when to order genetic testing, how the patient should be evaluated for genetic testing and the genetic causes of SCA.
Challenges in the Development of Novel Cardiovascular Therapies: New Target for Lowering LDL: PCSK-9 - Cardiology Grand Rounds
Chief Medical Officer of Amgen, Paul Eisenberg, MD, discusses the insights he has learned working on drug development, specifically the cardiovacscular drug that lowers LDL, PCSK-9.
At Barnes-Jewish Hospital, A Wider Organ Donor Pool Saves Lives
The DCD program at Barnes-Jewish Hospital and WashU Medicine was initiated in response to the increasing waiting periods for heart transplants, despite the 2018 changes in organ allocation aimed at reducing wait list mortality.
Empowering our Youth: How Teaching CPR in Schools Creates a Generation of First-Responders (and Saves Lives!) – 2016 AHA Symposium, Part 7
Lindsay Davis, Miss Ohio 2011 and patient advocate for SCA, discusses the importance of making CPR mandatory in high school.
Aortic Surgery: Personalized Medicine with a Team Approach
Dr. Puja Kachroo, MD shares about the evolution of Aortic Surgery including valve sparing procedures and aortic arch procedures.
Aortic Valve Disease in Primary Care: What to know, what to do and when to get concerned
Dr. Marc Sintek shared an overview of Aortic Valve Disease as it relates to patients presenting to a primary care practice.
Marye Gleva, MD, Cardiologist, Heart Rhythm Specialist
Dr. Marye Gleva is a cardiac electrophysiologist at the Washington University and Barnes-Jewish Heart & Vascular Center, specializing in heart arrhythmia disorders.
Advanced Heart Valve Procedures Expand Treatments for Patients With Limited Options
Heart specialists at the Washington University and Barnes-Jewish Heart & Vascular Center in St. Louis, Mo., are pioneering advances that enhance the quality of life for patients who have historically suffered debilitating symptoms with limited therapeutic options.
Heart Failure in African Americans: A Still Unresolved Question – Cardiology Grand Rounds
Northwestern University cardiologist Clyde W. Yancy, MD, MSc, discusses heart failure in African Americans, who have a disproportionate burden of heart disease. Dr. Yancy discusses how there is a need for treatment to reduce the effects of heart disease within the African American population.
Atrial Fibrillation: Impact and Future Developments - Cardiology Grand Rounds
Cleveland Clinic cardiologist Bruce D. Lindsay, MD, FACC, FHRS, gives the viewer insight into the future of atrial fibrillation. Dr. Lindsay discusses the mapping of AF, types of AF and what advances in technology may alter current approaches to ablation
JNC 8 et al.: Is Evidence-Based Medicine the Only Way? – Cardiology Grand Rounds
Dr. George Bakris of the The University of Chicago Medicine presents JNC 8 et al.: Is Evidence-Based Medicine the Only Way?
Microvascular Disease: Detection and Treatment Strategies
The microvasculature can be imaged at the bedside with continuous infusion of microbubbles (ultrasound contrast agents) or a slow bolus injection.
